Document is current
Any future updates will be listed below
-
Authors
Li, Qing
de Oliveira Formiga, Rodrigo
Puchois, Virginie
Creusot, Laura
Ahmad, Ahmad Haidar
Amouyal, Salomé
Campos-Ribeiro, Márcio Augusto https://orcid.org/0000-0002-8431-4968
Zhao, Yining
Harris, Danielle M. M. https://orcid.org/0000-0002-1950-399X
Lasserre, Frederic
Ellero-Simatos, Sandrine https://orcid.org/0000-0002-9282-1804
Guillou, Hervé
Huang, Zhan
Brot, Loic
Hu, Yuhang
Chollet, Loic https://orcid.org/0009-0005-0165-625X
Danne, Camille https://orcid.org/0000-0003-0971-8310
Scandola, Cyril https://orcid.org/0000-0002-5305-9095
Ledent, Tatiana
Chevreux, Guillaume
Argüello, Rafael J. https://orcid.org/0000-0001-9785-3883
De Carvalho Bittencourt, Marcelo
Bettinger, Jessica https://orcid.org/0009-0003-1129-2408
D’Aveni-Piney, Maud
Moulin, David https://orcid.org/0000-0001-6619-5769
Schreiber, Stefan https://orcid.org/0000-0003-2254-7771
Aden, Konrad https://orcid.org/0000-0003-3482-7316
Rolhion, Nathalie
Michel, Marie-Laure
Wai, Timothy https://orcid.org/0000-0002-6770-6222
Sokol, Harry https://orcid.org/0000-0002-2914-1822
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 17 September 2025
First Online: 21 October 2025
Competing interests
: H.S. reports lecture fees, board membership or consultancy from Carenity, AbbVie, Astellas, Danone, Ferring, Mayoly Spindler, MSD, Novartis, Roche, Tillots, Enterome, BiomX, Takeda and Biocodex, has stocks from Enterome, and is co-founder of Exeliom Biosciences. K.A. reports lecture fees, board membership or consultancy from AbbVie, Ferring, Johnson & Johnson, Takeda and Lilly. All other authors declare no competing interests.
